Company Filing History:
2 out of 21,595 
1 out of 92 
Years Active: 1992-1999
Title: The Innovations of Elizabeth A. Grogan
Introduction
Elizabeth A. Grogan is a notable inventor based in Rochester, NY (US). She has made significant contributions to the field of diagnostics and assay development, holding a total of 3 patents. Her work has been instrumental in advancing methodologies for detecting specific binding ligands and microorganisms.
Latest Patents
One of her latest patents is titled "Specific binding assay using enzyme inhibitor and anti-inhibitor." This innovative assay utilizes an immobilized receptor for the ligand, an immobilized reporter enzyme, an inhibitor antibody, and a water-soluble conjugate of the ligand and an anti-inhibitor antibody. The unique combination of these components allows for a direct correlation of the generated signal to the target specific binding ligand.
Another significant patent is focused on a "Test kit and method for the detection of microorganisms associated with." This patent describes an extraction composition that is buffered to a pH from about 8 to about 11. It contains a water-soluble cationic surfactant and an anionic surfactant, which are used to extract antigens from specific bacteria. The extracted antigens can then be determined using immunological methods, making it a valuable tool in diagnostic test kits.
Career Highlights
Elizabeth has worked with prominent companies such as Eastman Kodak Company and Johnson & Johnson Clinical Diagnostics, Inc. Her experience in these organizations has contributed to her expertise in the field of diagnostics and assay development.
Collaborations
Throughout her career, Elizabeth has collaborated with notable individuals, including Brian A. Snyder and Paul B. Contestable. These collaborations have likely enriched her work and led to further innovations in her field.
Conclusion
Elizabeth A. Grogan's contributions to the field of diagnostics through her innovative patents and collaborations highlight her role as a significant inventor. Her work continues to impact the methodologies used in detecting specific binding ligands and microorganisms.